GlaxoSmithKlein’s WWFH Pennsylvania Vendor Summit at GSK’s union-built Navy Yard facility in Philadelphia brought together Senator Pat Toomey (R-PA) and about 75 business leaders, policy makers and non-profit leaders to discuss the sector’s economic impact and opportunities for growth.
PILMA Donates $125,000 to Helmets to Hardhats Program
The Pharmaceutical Industry Labor-Management Association (PILMA) presented Helmets to Hardhats with a check for $125,000 comprised of donations from pharmaceutical companies Eli Lilly, Johnson & Johnson, Merck, Novartis, and Pfizer during PILMA’s annual meeting on November 15.
Proposed Medicare Part D Prescription Drug Rebates Result in Diminished Multiemployer Plan Benefits
Ironworkers General President and Pharmaceutical Industry Labor-Management Association (PILMA) Chairman Walter Wise released the following statement today following the publication of PILMA’s new study Medicaid Drug Rebates in Medicare Part D Low-Income Subsidy
Impact of Medicare Part D Rebates on Multi-employer Plans
Medicare Part D is a successful program that has brought prescription drug coverage to millions of seniors, while keeping costs lower than expected with high levels of beneficiary satisfaction.
Medicare Part D Rebates Have Unintended Consequences
Jay Potesta, Political Director of the Sheet Metal Workers’ International Association, wrote the following op-ed published in NWI Times details how the proposed Medicare Part D rebates will shift the cost burden from government to union members and seniors.
Proposed Medicare Part D Rebates Will Eliminate Jobs and Increase Drug Costs
PILMA Chairman Walter Wise send the following letter to the Chairman of the Senate Aging Committee urging protection of Medicare Part D benefits.